Equities Analysts Set Expectations for BIOX Q2 Earnings

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Equities research analysts at Brookline Capital Management dropped their Q2 2025 earnings per share (EPS) estimates for Bioceres Crop Solutions in a research note issued on Tuesday, November 12th. Brookline Capital Management analyst K. Dolliver now forecasts that the company will post earnings of $0.14 per share for the quarter, down from their previous estimate of $0.28. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.33 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ Q3 2025 earnings at $0.02 EPS and FY2025 earnings at $0.16 EPS.

A number of other analysts have also commented on BIOX. Roth Mkm cut their price target on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Lake Street Capital cut their target price on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Oppenheimer decreased their price target on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, October 21st. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Finally, Canaccord Genuity Group decreased their target price on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research report on Wednesday. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Bioceres Crop Solutions presently has a consensus rating of “Buy” and a consensus price target of $12.13.

Bioceres Crop Solutions Trading Down 6.1 %

BIOX opened at $6.42 on Friday. The stock has a market capitalization of $403.50 million, a P/E ratio of 321.16 and a beta of 0.49. The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 0.37. Bioceres Crop Solutions has a 12 month low of $5.71 and a 12 month high of $14.05. The firm’s fifty day simple moving average is $7.58 and its 200 day simple moving average is $9.80.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). The business had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same quarter last year, the firm earned ($0.07) EPS.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds have recently added to or reduced their stakes in BIOX. Fourth Sail Capital LP grew its stake in shares of Bioceres Crop Solutions by 61.6% in the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock valued at $24,957,000 after acquiring an additional 1,209,277 shares in the last quarter. Long Focus Capital Management LLC lifted its holdings in shares of Bioceres Crop Solutions by 19.9% in the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock worth $3,145,000 after acquiring an additional 46,647 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in Bioceres Crop Solutions in the second quarter valued at approximately $472,000. Ping Capital Management Inc. acquired a new stake in shares of Bioceres Crop Solutions during the 2nd quarter valued at $448,000. Finally, Lazard Asset Management LLC bought a new stake in shares of Bioceres Crop Solutions during the first quarter worth about $212,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.